Dementia

About Webinar

ConferenceSeries LLC LTD takes immense pleasure and extends a warm welcome to attend the Webinar on Dementia 2021 for a series of webinars that discuss how dementia and Alzheimer's research can move science forward despite the barriers created by the COVID-19 pandemic. The Dementia webinar is scheduled during September 28, 2021. These webinars share the latest advances in neuroscience, as well as strategies for career development and researcher education.

Dementia 2021 are the kind gathering to unite overall recognized scholastics in the field of neuroscience and neurology, brain specialists, general wellbeing experts, researchers, scholastic researchers, industry analysts, researchers to trade about best in class research and advances. The aim of the webinar is to gather new thoughts for treatment that will be gainful over the range of Neuroscience and sharing knowledge and skills on this on-stream meet

 

Session/Tracks

Session 1 on Dementia

Dementia is a syndrome in which deterioration in the memory, thinking and causes other problems in the brain and often gradual decrease in the ability to think and remember that is great enough to affect a person's daily functioning. Other common symptoms include emotional problems, problems with language, and a decrease in motivation. In the early stage of dementia, people gradually lose their character and starting some changes in the behaviour. In the middle stage dementia somewhat seen clearly by some of the symptoms. The last stage is the severe stage, it cannot be cured.

People with dementia are frequently loses their basic rights and difficult to lead the normal life. The families of affected people also suffer a lot to survive. They face many problems in the society in physical, mental and social pressure. The seven stages of syndrome are,

• No impairment
• Very mild cognitive decline
• Moderate cognitive decline
• Mild cognitive decline

Session 2 on Alzheimers Disease

Alzheimers disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. The most common early symptom is difficulty in remembering recent events short-term memory loss. [As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self-care, and behavioural issues. As a person's condition declines, they often withdraw from family and society.  Gradually, bodily functions are lost, ultimately leading to death.

In this session we are able to discuss on medical specialty changes in

• Brain
• Amyloid super molecule,
• Genetic associations
• susceptibleness genes,
• Role of Apo conjugated protein E

Session 3 on Neurological Disorder

Neurological Disorder is the any disorder in the nervous system and causes problems in the brain and the spinal cord. It changes the biochemical actions of the brain cells and leads to variation in the structure. Amyotrophic lateral sclerosis is the progressive neurodegenerative disease that causes defect in the brain cells and the spinal cord. The amyotrophic is comes from Greek language A means No, Myo means Muscle and Trophic means Nourishment, amyotrophic means No Muscle Nourishment. Aneurysm refers to weakening of an artery valve leads to the bulging of valves or distension that further creates the rupturing of artery valves leads to the life threatening conditions. In some cases it doesn’t show any symptoms and it may not cause any dangerous, it suppressed.

• Motor neuron diseases
• Prion diseases
• Schizophrenia
• Autism child
• ADD and ADHD
• Insomnia

Session 4 on Diagnostic Alzheimer’s & Novel Therapeutics

Novel therapeutics is a standout among the most energizing uses of facts making ready frameworks is in diagnostics and treatment. This is not astonishing, given that contamination analysis is in its centre a statistics handling assignment that finishes with a choice. In severe infections, the conclusion can be done in singular cells. Doctors cannot analyse Alzheimer's disease until after death, when they are able to nearly inspect the brain beneath a magnifying instrument. 

• Diagnostic Alzheimer
• Neuropsychological testing
• Precision Medicine for Alzheimer Disease
• Novel therapeutics strategies for Dementia
• Novel therapeutics molecule

Session 5 on Anxiety & Depression

Apathy, depression and anxiety are common conditions experienced by people with dementia. They are known as psychological conditions because they can affect a person’s emotional and mental health. Anxiety is more than just feeling stressed or worried. Anxious feelings are a normal reaction to a situation where a person feels under pressure and usually pass once the stressful situation has passed, or the ‘stressor’ is removed. Depression affects how a person feels about themselves. A person may lose interest in work, hobbies and doing things he or she normally enjoys. Some people may lack energy, have difficulty sleeping or sleep more than usual, while some people feel anxious or irritable and find it hard to concentrate.

Common symptoms are:

• Panic, fear, and uneasiness
• Feelings of panic, doom, or danger
• Sleep problems
• Not being able to stay calm and still
• Cold, sweaty, numb, or tingling hands or feet
• Shortness of breath
• Breathing faster and more quickly than normal (hyperventilation)
• Heart palpitations